These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 8451041
1. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck. Pai VR, Parikh DM, Mazumdar AT, Rao RS. Oncology; 1993; 50(2):86-91. PubMed ID: 8451041 [Abstract] [Full Text] [Related]
7. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck. Thurnher D, Kornfehl J, Burian M, Gedlicka C, Selzer E, Quint C, Neuchrist C, Kornek GV. Anticancer Drugs; 2001 Mar; 12(3):205-8. PubMed ID: 11290867 [Abstract] [Full Text] [Related]
10. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK. Cancer; 2002 Jul 15; 95(2):322-30. PubMed ID: 12124833 [Abstract] [Full Text] [Related]
11. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. Recchia F, Lalli A, Lombardo M, De Filippis S, Saggio G, Fabbri F, Rosselli M, Capomolla E, Rea S. Cancer; 2001 Aug 15; 92(4):814-21. PubMed ID: 11550152 [Abstract] [Full Text] [Related]
12. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma. Hanauske AR, Schilling T, Heinrich B, Kau R, Herzog M, Quasthoff S, Bochtler H, Diergarten K, Rastetter J. Semin Oncol; 1995 Dec 15; 22(6 Suppl 14):35-9. PubMed ID: 8553082 [Abstract] [Full Text] [Related]
13. Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer. Forastiere AA, Urba SG. Semin Oncol; 1995 Jun 15; 22(3 Suppl 6):24-7. PubMed ID: 7597431 [Abstract] [Full Text] [Related]
14. Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial. Sandler A, Saxman S, Bandealy M, Heilman D, Monaco F, McClean J, Arquette M. Am J Clin Oncol; 1998 Apr 15; 21(2):195-7. PubMed ID: 9537211 [Abstract] [Full Text] [Related]
15. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G, Fei F, Mangioni C. Semin Oncol; 2000 Feb 15; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [Abstract] [Full Text] [Related]
18. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck. Specenier PM, Van Den Brande J, Schrijvers D, Huizing MT, Altintas S, Dyck J, Van Den Weyngaert D, Van Laer C, Vermorken JB. Anticancer Res; 2009 Dec 15; 29(12):5137-42. PubMed ID: 20044628 [Abstract] [Full Text] [Related]
19. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck. Benner SE, Lippman SM, Huber MH, Hong WK. Semin Oncol; 1995 Oct 15; 22(5 Suppl 12):22-5. PubMed ID: 7481857 [Abstract] [Full Text] [Related]